DocGo’s (DCGO) Buy Rating Reaffirmed at Needham & Company LLC

DocGo (NASDAQ:DCGO)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. They currently have a $4.00 price objective on the stock. Needham & Company LLC’s price target would suggest a potential upside of 55.64% from the stock’s current price.

Other equities research analysts also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft downgraded shares of DocGo from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $5.00 to $2.85 in a research note on Friday, February 28th. Stifel Nicolaus decreased their target price on shares of DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research report on Friday, February 28th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, DocGo has an average rating of “Moderate Buy” and an average price target of $4.89.

DocGo Trading Up 2.4 %

NASDAQ:DCGO opened at $2.57 on Tuesday. The firm has a 50-day moving average price of $3.62 and a two-hundred day moving average price of $3.85. The company has a market capitalization of $262.10 million, a P/E ratio of 9.18, a price-to-earnings-growth ratio of 14.16 and a beta of 1.12. DocGo has a twelve month low of $2.39 and a twelve month high of $5.68.

Institutional Trading of DocGo

Hedge funds have recently made changes to their positions in the stock. Invesco Ltd. grew its holdings in DocGo by 1.3% during the fourth quarter. Invesco Ltd. now owns 177,953 shares of the company’s stock valued at $755,000 after purchasing an additional 2,312 shares during the last quarter. Summit Investment Advisors Inc. increased its position in DocGo by 38.7% in the fourth quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock worth $45,000 after purchasing an additional 2,968 shares during the period. SG Americas Securities LLC grew its position in shares of DocGo by 12.9% during the 4th quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock worth $183,000 after buying an additional 4,905 shares during the period. Rhumbline Advisers grew its position in shares of DocGo by 4.5% in the 4th quarter. Rhumbline Advisers now owns 142,762 shares of the company’s stock valued at $605,000 after purchasing an additional 6,204 shares during the period. Finally, Victory Capital Management Inc. grew its position in shares of DocGo by 12.3% in the 4th quarter. Victory Capital Management Inc. now owns 57,649 shares of the company’s stock valued at $244,000 after purchasing an additional 6,300 shares during the period. 56.44% of the stock is owned by hedge funds and other institutional investors.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.